Award Abstract # 1918585
PFI-TT: Affordable and High-Quality Polyethylene Glycols for Nanomedicine and Other Applications

NSF Org: TI
Translational Impacts
Recipient: MICHIGAN TECHNOLOGICAL UNIVERSITY
Initial Amendment Date: July 8, 2019
Latest Amendment Date: July 8, 2019
Award Number: 1918585
Award Instrument: Standard Grant
Program Manager: Jesus Soriano Molla
jsoriano@nsf.gov
 (703)292-7795
TI
 Translational Impacts
TIP
 Directorate for Technology, Innovation, and Partnerships
Start Date: August 1, 2019
End Date: July 31, 2022 (Estimated)
Total Intended Award Amount: $250,000.00
Total Awarded Amount to Date: $250,000.00
Funds Obligated to Date: FY 2019 = $250,000.00
History of Investigator:
  • Shiyue Fang (Principal Investigator)
    shifang@mtu.edu
Recipient Sponsored Research Office: Michigan Technological University
1400 TOWNSEND DR
HOUGHTON
MI  US  49931-1200
(906)487-1885
Sponsor Congressional District: 01
Primary Place of Performance: Michigan Technological University
MI  US  49931-1295
Primary Place of Performance
Congressional District:
01
Unique Entity Identifier (UEI): GKMSN3DA6P91
Parent UEI: GKMSN3DA6P91
NSF Program(s): PFI-Partnrships for Innovation
Primary Program Source: 01001920DB NSF RESEARCH & RELATED ACTIVIT
Program Reference Code(s): 8030
Program Element Code(s): 166200
Award Agency Code: 4900
Fund Agency Code: 4900
Assistance Listing Number(s): 47.084

ABSTRACT

The broader impact/commercial potential of this Partnerships for Innovation (PFI) project is the development of a new way to make a special class of chemicals, polyethylene glycols (PEGs). PEGs are neutral, stable, flexible, non-toxic and dissolve easily, and thus they are used in many applications, including pharmaceutical products and other biomedical applications. However, it is difficult to make PEGs with enough purity and consistency for use in more advanced pharmaceutical applications, and for other uses, the right PEG simply cannot be made. This PFI project will develop and commercialize novel ways to synthesize PEGs. The new affordable and highly pure PEGs will generate higher quality and lower prices for drugs using them; similarly, many biomedical and related research projects requiring PEGs will be more affordable and will generate more consistent results.

The proposed project will advance the knowledge needed for the synthesis of highly pure PEGs with affordable prices. Currently, pure PEGs shorter than those with 64 ethylene glycol monomer units can be synthesized, but the methods require multiple expensive reaction workups and chromatography, and the products have limited purity. In addition, pure PEGs longer than 64 ethylene glycol monomer units with acceptable purity cannot be synthesized using any known methods. The technical hurdles that cause these problems of PEG synthesis include the difficulty to separate PEG products and impurities, slow reaction rates, and depolymerization side reactions. The research objective of this project is to gain the knowledge needed to overcome these technical hurdles. The approaches include using solid phase synthesis instead of traditional solution phase synthesis, innovative stepwise synthesis monomers, and automated synthesis using a peptide synthesizer. Using these approaches, the products will be easily isolated without tedious workup and purified without expensive chromatography, the reaction rates will be increased, the depolymerization side reaction will be suppressed, and the process will require minimal labor. It is expected that once detailed knowledge about using these approaches are obtained, pure PEGs with unprecedented high quality and low costs will be conveniently produced.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

PUBLICATIONS PRODUCED AS A RESULT OF THIS RESEARCH

Note:  When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

Eriyagama, Dhananjani N.A.M. and Yin, Yipeng and Fang, Shiyue "Automated stepwise PEG synthesis using a base-labile protecting group" Tetrahedron , v.119 , 2022 https://doi.org/10.1016/j.tet.2022.132861 Citation Details
Mikesell, Logan and Eriyagama, Dhananjani N and Yin, Yipeng and Lu, Bao-Yuan and Fang, Shiyue "Stepwise PEG synthesis featuring deprotection and coupling in one pot" Beilstein Journal of Organic Chemistry , v.17 , 2021 https://doi.org/10.3762/bjoc.17.207 Citation Details

PROJECT OUTCOMES REPORT

Disclaimer

This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.

The research objective of this Partnerships for Innovation (PFI) project is to gain the knowledge needed to overcome the technical hurdles for the synthesis of polyethylene glycols (PEGs). Among many of the technical discoveries during the course of the project, a protecting group that is seemingly unsuitable for PEG synthesis has been found to be suitable for the purpose. This protecting group is called base-labile protecting group, which means it can be removed with a base after it finishes its protection task. Protecting groups previously used for PEG synthesis are all non-base-labile, and they are removed by reagents that are not basic.  Using the base-labile protecting group, PEG synthesis routes can be as much as 30% shorter, which significantly lowers materials and labor for PEG synthesis. The base-labile protecting group also makes the synthesis more efficient, which means less reaction time, less amount of reagent, and higher yield of product. Another important discovery of the project is the feasibility of automation of the process of PEG synthesis. The PEG intermediates and products are anchored onto an insoluble solid support,  and reagents for the PEG synthesis are delivered to a reaction vessel sequentially by a modified peptide synthesizer controlled by a computer. After a reaction is complete, excess reagents and side products are washed away, also under control by the computer. The PEG intermediate or product on the insoluble solid support remains in the reaction vessel, waiting for the reaction of the next step to take place. The process continues automatically until the reactions of all steps required for the PEG synthesis are accomplished. The entire, otherwise complicated and highly labor intensive, process does not require any human manipulation once the synthesis is initiated. The major advantage of the automated PEG synthesis is the reduction of labor. Other advantages include saving materials for the synthesis and potentially more pure products. The above two discoveries, base-labile protecting group and automated PEG synthesis, along with other technical discoveries such as suitable reagents and solvents, appropriate washing schemes, and tactics for preventing side reactions have been integrated to give an efficient automated PEG synthesis technology, which has all the advantages described above for the discoveries. Using the integrated technology, the synthesis of several PEG derivatives with close to 100% yield and purity has been demonstrated.

The discoveries have the potential to make PEGs including their derivatives much cheaper. PEGs have wide applications including nanomedicine (e.g. COVID-19 mRNA vaccine), drug PEGylation (e.g. delivery of protein and gene based drugs), and bioconjugation. Lowering the cost of PEGs can lower the production costs of many medicines and other materials. While carrying out this PFI project, two PhD students received training in organic synthesis and automated solid phase synthesis. One of them has graduated, and is now an employee of a Fortune 500 company in the US doing work related to automated synthesis. Earlier, another PhD student also received training from the project. He underwent the intensive NSF I-Corps training related to this project. He is now an employee of a startup company in the US that is backed up by several Fortune 500 companies. His work in the company is also related to automated synthesis. In addition, one MS student and two undergraduate students also received training in organic synthesis via this PFI project. Among the trainees, one PhD student and one undergraduate student are female students. The trainees of this PFI project are or will be part of the workforce that makes the US competitive in science and technology in the world. 


Last Modified: 11/26/2022
Modified by: Shiyue Fang

Please report errors in award information by writing to: awardsearch@nsf.gov.

Print this page

Back to Top of page